Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C

Simple item page
dc.contributor.authorLeng, Boonwaat
dc.contributor.authorHaber, Paul
dc.contributor.authorLevy, Michael
dc.contributor.authorLloyd, Andrew
dc.date.accessioned2015-12-10T22:23:30Z
dc.date.available2015-12-10T22:23:30Z
dc.date.issued2010
dc.date.updated2016-02-24T10:41:54Z
dc.description.abstractObjective: To evaluate the assessment and treatment outcomes of a prison hepatitis service. Design and setting: A retrospective, observational cohort study of prison inmates who attended hepatitis clinics from 1996 to 2005 at correctional centres in New South Wales. Patients: Inmates who attended the clinics, including a nested case-control series of patients who received antiviral treatment and age- and sex-matched patients who did not receive treatment. Main outcome measures: Demographic and clinical characteristics of patients who attended the service; correlates of selection for antiviral treatment; and clinical and virological outcomes of treatment. Results: Of the 1043 inmates who attended the clinics, 851 were men (82%) and 994 (95%) were referred for HCV infection; the mean age for this group was 33 years (range, 18-74 years). In the case-control series (185 treated and 186 untreated patients), selection for treatment was not biased by culturally and linguistically diverse background, current methadone treatment or psychiatric status. In the treated group, 76 of 138 genotyped patients had a genotype that is predictive of favourable treatment response, and a small minority of those with available liver biopsy results had established cirrhosis (7/119 patients). Of treated patients for whom complete follow-up data were available, 55% achieved sustained virological response and 100% adhered to therapy. In addition, treatment episodes were not especially complicated. Conclusion: Although the prison population has high rates of injecting drug use and poor mental health, imprisonment offers an opportunity for assessment and treatment of chronic HCV infection.
dc.identifier.issn0025-729X
dc.identifier.urihttp://hdl.handle.net/1885/52822
dc.publisherAustralasian Medical Association
dc.sourceMedical Journal of Australia
dc.subjectKeywords: methadone; adult; aged; antiviral therapy; article; Australia; case control study; cohort analysis; controlled study; female; genotype; hepatitis C; human; liver biopsy; liver cirrhosis; major clinical study; male; observational study; outcome assessment;
dc.titleEstablishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C
dc.typeJournal article
local.bibliographicCitation.issue9
local.bibliographicCitation.lastpage500
local.bibliographicCitation.startpage496
local.contributor.affiliationLeng, Boonwaat, Justice Health
local.contributor.affiliationHaber, Paul, Royal Prince Alfred Hospital
local.contributor.affiliationLevy, Michael, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationLloyd, Andrew, University of New South Wales
local.contributor.authoremailu5085992@anu.edu.au
local.contributor.authoruidLevy, Michael, u5085992
local.description.notesImported from ARIES
local.identifier.absfor110309 - Infectious Diseases
local.identifier.absfor111799 - Public Health and Health Services not elsewhere classified
local.identifier.ariespublicationu4201517xPUB256
local.identifier.citationvolume192
local.identifier.scopusID2-s2.0-77952407655
local.identifier.thomsonID000277753200005
local.identifier.uidSubmittedByu4201517
local.type.statusPublished Version

Downloads

Collections

ANU Research Publications

DSpace software copyright © 2002-2024 LYRASIS